Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Palzkill

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Molecular Microbiology|April 1, 1994
Evolution of antibiotic resistance: several different amino acid substitutions in an active site loop alter the substrate profile of beta-lactamaseT Palzkill, Q Q Le, K V Venkatachalam, et al.
Proteins|May 1, 1996
The rate-limiting step in the folding of the cis-Pro167Thr mutant of TEM-1 beta-lactamase is the trans to cis isomerization of a non-proline peptide bondM Vanhove, X Raquet, T Palzkill, et al.
Antimicrobial Agents and Chemotherapy|September 16, 1998
Characterization of a PSE-4 mutant with different properties in relation to penicillanic acid sulfones: importance of residues 216 to 218 in class A beta-lactamasesY Sabbagh, E Thériault, F Sanschagrin, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1995
New variant of TEM-10 beta-lactamase gene produced by a clinical isolate of proteus mirabilisT Palzkill, K S Thomson, C C Sanders, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1992
Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patientsL Naumovski, J P Quinn, D Miyashiro, et al.
The Journal of Infectious Diseases|October 4, 2000
Human immune response to streptococcal inhibitor of complement, a serotype M1 group A Streptococcus extracellular protein involved in epidemicsN P Hoe, P Kordari, R Cole, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Molecular Microbiology|April 1, 1994
Evolution of antibiotic resistance: several different amino acid substitutions in an active site loop alter the substrate profile of beta-lactamaseT Palzkill, Q Q Le, K V Venkatachalam, et al.
Proteins|May 1, 1996
The rate-limiting step in the folding of the cis-Pro167Thr mutant of TEM-1 beta-lactamase is the trans to cis isomerization of a non-proline peptide bondM Vanhove, X Raquet, T Palzkill, et al.
Antimicrobial Agents and Chemotherapy|September 16, 1998
Characterization of a PSE-4 mutant with different properties in relation to penicillanic acid sulfones: importance of residues 216 to 218 in class A beta-lactamasesY Sabbagh, E Thériault, F Sanschagrin, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1995
New variant of TEM-10 beta-lactamase gene produced by a clinical isolate of proteus mirabilisT Palzkill, K S Thomson, C C Sanders, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1992
Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patientsL Naumovski, J P Quinn, D Miyashiro, et al.
The Journal of Infectious Diseases|October 4, 2000
Human immune response to streptococcal inhibitor of complement, a serotype M1 group A Streptococcus extracellular protein involved in epidemicsN P Hoe, P Kordari, R Cole, et al.
Pageof 4